Journal Of Clinical Psychopharmacology

Journal Of Clinical Psychopharmacology

临床精神药理学杂志

  • 3区 中科院分区
  • Q2 JCR分区

期刊简介

《Journal Of Clinical Psychopharmacology》是由Lippincott Williams and Wilkins Ltd.出版社于1981年创办的英文国际期刊(ISSN: 0271-0749,E-ISSN: 1533-712X),该期刊长期致力于药学领域的创新研究,主要研究方向为医学-精神病学。作为SCIE收录期刊(JCR分区 Q2,中科院 3区),本刊采用OA未开放获取模式(OA占比0.0572...%),以发表药学领域等方向的原创性研究为核心(研究类文章占比86.89%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在61篇,确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Journal Of Clinical Psychopharmacology审稿周期约为 偏慢,4-8周 。该刊近年未被列入国际预警名单,年发文量约61篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCIE 期刊收录
  • 61 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
3区
PHARMACOLOGY & PHARMACY 药学 PSYCHIATRY 精神病学
3区 4区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
4区
PHARMACOLOGY & PHARMACY 药学 PSYCHIATRY 精神病学
4区 4区

JCR分区

按JIF指标学科分区 收录子集 分区 排名 百分位
学科:PHARMACOLOGY & PHARMACY SCIE Q2 147 / 354

58.6%

学科:PSYCHIATRY SCIE Q2 98 / 276

64.7%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:PHARMACOLOGY & PHARMACY SCIE Q2 177 / 354

50.14%

学科:PSYCHIATRY SCIE Q3 151 / 276

45.47%

CiteScore

CiteScore SJR SNIP CiteScore 排名
CiteScore:4 SJR:0.728 SNIP:0.855
学科类别 分区 排名 百分位
大类:Medicine 小类:Psychiatry and Mental Health Q2 249 / 567

56%

大类:Medicine 小类:Pharmacology (medical) Q2 126 / 272

53%

期刊发文

  • Effects of Cytochrome P450 2C19 Genetic Polymorphisms on Responses to Escitalopram and Levels of Brain-Derived Neurotrophic Factor in Patients With Panic Disorder.

    Author: He Q, Mei Y1, Liu Y2, Yuan Z3, Zhang J4, Yan H3, Shen L3, Zhang Y4.

    Journal: J Clin Psychopharmacol. 2019 Mar/Apr;39(2):117-123. doi: 10.1097/JCP.0000000000001014.

  • A Randomized, 8-Week Study of the Effects of Extended-Release Paliperidone and Olanzapine on Heart Rate Variability in Patients With Schizophrenia.

    Author: Pu ZP, Li GR, Zou ZP1, Tao F2, Hu SH3.

    Journal: J Clin Psychopharmacol. 2019 May/Jun;39(3):243-248. doi: 10.1097/JCP.0000000000001023.

  • Longitudinally Measured Changes in Somnolence Severity With a Visual Analog Scale in a Randomized Lithium Versus Quetiapine-IR Study in Bipolar Disorder.

    Author: Gao K, Su M1, Ganocy SJ, Goto T, Yuan C2, Fang F3, Conroy C, Brownrigg B, Serrano MB, Calabrese JR.

    Journal: J Clin Psychopharmacol. 2019 May/Jun;39(3):249-253. doi: 10.1097/JCP.0000000000001031.

  • Insulin Resistance-Related Proteins Are Overexpressed in Patients and Rats Treated With Olanzapine and Are Reverted by Pueraria in the Rat Model.

    Author: Yang N, Li S, Liu S1, Lv Y1, Yu L, Deng Y, Li H, Fang M2, Huo Y3, Li W, Peng S1.

    Journal: J Clin Psychopharmacol. 2019 May/Jun;39(3):214-219. doi: 10.1097/JCP.0000000000001028.

  • Utilization of Psychopharmacological Treatment Among Patients With Newly Diagnosed Bipolar Disorder From 2001 to 2010.

    Author: Chang CM, Wu CS, Huang YW, Chau YL, Tsai HJ.

    Journal: J Clin Psychopharmacol. 2016 Feb;36(1):32-44. doi: 10.1097/JCP.0000000000000440.

  • Extrapyramidal Symptoms During Risperidone Maintenance Treatment in Schizophrenia: A Prospective, Multicenter Study.

    Author: Bo QJ, Li XB, Wang ZM, Li AN, Ma X, Wang CY.

    Journal: J Clin Psychopharmacol. 2016 Apr;36(2):125-9. doi: 10.1097/JCP.0000000000000464.

  • Efficacy of High-Dose Supplementation With Oral Vitamin D3 on Depressive Symptoms in Dialysis Patients With Vitamin D3 Insufficiency: A Prospective, Randomized, Double-Blind Study.

    Author: Wang Y, Liu Y, Lian Y, Li N, Liu H, Li G.

    Journal: J Clin Psychopharmacol. 2016 Jun;36(3):229-35. doi: 10.1097/JCP.0000000000000486.

  • Randomized trials published in Chinese or Western journals: comparative empirical analysis.

    Author: Purgato M, Cipriani A, Barbui C.

    Journal: J Clin Psychopharmacol. 2012 Jun;32(3):354-61. doi: 10.1097/JCP.0b013e3182546ef6.